FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 23 filers reported holding FATE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $12,000 | -14.3% | 4,596 | 0.0% | 0.00% | – |
Q3 2016 | $14,000 | +100.0% | 4,596 | +6.2% | 0.00% | – |
Q2 2016 | $7,000 | -12.5% | 4,327 | 0.0% | 0.00% | – |
Q1 2016 | $8,000 | -46.7% | 4,327 | 0.0% | 0.00% | – |
Q4 2015 | $15,000 | -34.8% | 4,327 | 0.0% | 0.00% | – |
Q3 2015 | $23,000 | -11.5% | 4,327 | +5.9% | 0.00% | – |
Q2 2015 | $26,000 | +136.4% | 4,085 | +87.5% | 0.00% | – |
Q1 2015 | $11,000 | 0.0% | 2,179 | -3.1% | 0.00% | – |
Q4 2014 | $11,000 | 0.0% | 2,248 | 0.0% | 0.00% | – |
Q3 2014 | $11,000 | -15.4% | 2,248 | +8.4% | 0.00% | – |
Q2 2014 | $13,000 | – | 2,073 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |